Skip header and navigation

10 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
February 12, 2021 How effective is surveillance antigenic testing? EOC012601 RR EOC
December 18, 2020 What is the risk of COVID-19 transmission during AGMP procedures? PPE120901 RR Personal Protective Equipment
December 1, 2020 What are the recommendations around settling times following aerosol generating procedures on suspected or confirmed COVID-19 patients? [Update] EOC081401v2 RR EOC
September 8, 2020 What are the safety risks or disinfection concerns with the use of intubation boxes? EOC090202 RR EOC
June 3, 2020 What proportion of disease transmission is due to persons who are asymptomatic over the entire course of illness? EPM051301 RR Epidemiology & Modelling
May 15, 2020 Do neck or back coverings provide additional protection to gown and N95 mask when conducting an aerosol generating procedure? EOC051201 RR EOC
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
April 27, 2020 What is the period of communicability of symptomatic SARS-CoV-2? INF042401 RR Infectious Disease
April 1, 2020 What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments? EOC040101 RR EOC
March 30, 2020 Where and how are they producing and using intubation hoods? EOC033001 RR EOC

10 records – page 1 of 1.